Latest / What's Your Problem? / Why Doctors Use Evidence but Managers (Mostly) Don’t
Transcript
- 0:15Speaker 1: Pushkin. I'm Jacob Goldstein, and this is what's your problem.
- 0:33Speaker 1: My guest today is Helen Pearson. She's a science journalist.
- 0:37Speaker 1: She writes for the journal Nature, and she recently wrote
- 0:40Speaker 1: a book called Beyond Belief, How Evidence Shows What Really works.
- 0:45Speaker 1: Helen's problem is this, how do you get people to
- 0:48Speaker 1: make important decisions based on high quality evidence rather than
- 0:52Speaker 1: hunches or habits. To a large extent, the book is
- 0:56Speaker 1: a history of what Helen calls the evidence revolution, and
- 1:00Speaker 1: this is a remarkably recent revolution. In her telling, fifty
- 1:04Speaker 1: years ago, she writes, doctors did not typically try to
- 1:08Speaker 1: sort through through the high quality published studies to figure
- 1:12Speaker 1: out what they should do. Instead, they often did whatever
- 1:15Speaker 1: they'd been taught in medical school, or what the senior
- 1:18Speaker 1: doctor in the room said to do, even if the
- 1:20Speaker 1: evidence said otherwise. But a few doctors spent their careers
- 1:25Speaker 1: trying to change that, sorting through all the evidence to
- 1:28Speaker 1: figure out what worked best in different situations, and trying
- 1:31Speaker 1: to get their fellow doctors to pay attention. In more
- 1:34Speaker 1: recent decades, that spirit has started to spread to other fields,
- 1:37Speaker 1: feels like management and crime prevention and education. Later in
- 1:41Speaker 1: the conversation, Helen and I talk about some of those fields,
- 1:45Speaker 1: places where the evidence is still often unclear, and where
- 1:48Speaker 1: people often ignore the evidence even when it is clear.
- 1:52Speaker 1: We also talk about how she uses evidence in her
- 1:54Speaker 1: own life and about the prospects for the spread of
- 1:57Speaker 1: evidence based decision making in the world. To start, we
- 2:01Speaker 1: talk about one doctor who did a lot to get
- 2:03Speaker 1: the evidence revolution going in medicine. His name was Ian Chalmers.
- 2:09Speaker 2: Ian is really the reason I ended up writing the book.
- 2:13Speaker 2: He was training to be a doctor in the kind
- 2:15Speaker 2: of late nineteen sixties early nineteen seventies. He was working
- 2:18Speaker 2: in obstetrics and gynecology in Wales at the time, and
- 2:22Speaker 2: he noticed this sort of odd thing, which was that
- 2:24Speaker 2: when doctors would hand out advice to women with the
- 2:27Speaker 2: same condition, they would give different advice. So, you know,
- 2:29Speaker 2: some doctors would think it was really important to have
- 2:31Speaker 2: prenatal vitamins or not to drink during pregnancy, and other
- 2:35Speaker 2: doctors would say no such thing. And this was kind
- 2:38Speaker 2: of so extreme that Ian once told me that when
- 2:41Speaker 2: he was woken in the night to treat a woman,
- 2:44Speaker 2: the first thing he would say was what's wrong, and
- 2:46Speaker 2: the second thing he would say was who's treating her?
- 2:48Speaker 2: Because that was going to change. You know what he
- 2:50Speaker 2: did next raight, So what generally happened was that everyone
- 2:55Speaker 2: followed the advice of the most senior doctor in the room,
- 2:57Speaker 2: which is sometimes now called eminence based medicine.
- 3:00Speaker 1: Tell me about his work in Gaza and how that
- 3:05Speaker 1: writer influenced him.
- 3:07Speaker 2: Yeah, so that was another part of his train, which
- 3:10Speaker 2: was also kind of influential in him realizing that a
- 3:12Speaker 2: lot of what he'd been taught in medical school was wrong.
- 3:15Speaker 2: So he worked on a refugee camp in Gaza during
- 3:19Speaker 2: his medical training, and during that time he was treating
- 3:24Speaker 2: children who had measles, and he had been taught in
- 3:28Speaker 2: medical school that you shouldn't give antibiotics to a child
- 3:30Speaker 2: with measles, even if they were becoming quite sick, because
- 3:34Speaker 2: antibiotics treated bacterial infection, so why would you give it
- 3:37Speaker 2: to a child with a viral infection. So he followed
- 3:40Speaker 2: the advice he'd been taught, and he didn't give the antibiotics.
- 3:43Speaker 2: But then later when he returned to the UK, he
- 3:47Speaker 2: discovered that actually this advice he'd been given was tragically wrong,
- 3:50Speaker 2: and that there were in fact about six control clinical
- 3:53Speaker 2: trials that suggested it did help to give some children
- 3:57Speaker 2: antibiotics prophylactically because they were developing a secondary bacterial infection
- 4:01Speaker 2: along of the viral one.
- 4:03Speaker 1: And in fact, as I understand it, like he concluded
- 4:06Speaker 1: when he went back to the UK and studied the
- 4:08Speaker 1: advice that children under his care had probably died or
- 4:12Speaker 1: possibly died because he had done the wrong thing.
- 4:14Speaker 3: That's exactly right.
- 4:16Speaker 2: Yeah, So it's so a huge kind of you know,
- 4:18Speaker 2: turning point for him of realizing that.
- 4:20Speaker 1: So let me ask the native question, why had he
- 4:25Speaker 1: been taught something that was not consistent with the evidence.
- 4:28Speaker 2: Because that was that was standard practice in medical schools
- 4:33Speaker 2: at the time. Most doctors weren't really being taught about
- 4:35Speaker 2: clinical trials in the sixties and seventies.
- 4:38Speaker 3: Hard though it is to believe.
- 4:39Speaker 1: It is weird, right, it is hard to believe. I mean,
- 4:42Speaker 1: I guess is part of it the sort of formal
- 4:44Speaker 1: you know, randomized controlled trial. Well you have a placebo
- 4:48Speaker 1: arm and a treatment arm, and that people running the
- 4:50Speaker 1: trial don't know which is which. That was actually relatively
- 4:53Speaker 1: new still.
- 4:54Speaker 2: Right, exactly, Yes, So we feel like randomized trials have
- 4:57Speaker 2: been around for ages, but they are relatively new. I
- 5:00Speaker 2: mean around the time that you know that Ian was
- 5:02Speaker 2: having the you know that this realization that he hadn't
- 5:04Speaker 2: been taught about trials. They were really only then becoming commonplace.
- 5:09Speaker 1: Oh so you have this sort of research changing and
- 5:14Speaker 1: the practices of doctors are lagging. That is sort of
- 5:18Speaker 1: the moment when Ian Chalmers walks onto the scene. And
- 5:21Speaker 1: it's this moment when there is now research but doctors,
- 5:25Speaker 1: weirdly to our sensibilities, are not paying attention to it.
- 5:29Speaker 1: What does Chalmers do when he realizes this?
- 5:33Speaker 2: So what he did was he became very passionate about
- 5:39Speaker 2: randomized trials. Actually, and I discovered this with other people
- 5:43Speaker 2: I spoke to, is that there's something about this method
- 5:45Speaker 2: which is very captivating to people.
- 5:47Speaker 1: It's so elegant, right, like intellectually, like the it's blinded,
- 5:51Speaker 1: there's a placebo control. Like I recognize that they're imperfect,
- 5:55Speaker 1: and people love to talk about the problems with them,
- 5:57Speaker 1: but it's wildly elegant and not intuitive. Right People want
- 6:02Speaker 1: to just like give something to somebody and see if
- 6:04Speaker 1: they get better, and say it works if they get better,
- 6:06Speaker 1: and like, for so many reasons, a randomized trial is
- 6:09Speaker 1: so much better than that.
- 6:10Speaker 2: And that argument goes on all the time today. I mean,
- 6:13Speaker 2: that's what mostly happens in policy is we just introduce
- 6:16Speaker 2: policies right without bothering to test whether they're effective and
- 6:19Speaker 2: assuming they do good when some do harm. So that
- 6:21Speaker 2: I don't think that's an old argument.
- 6:23Speaker 1: We will get to policy. Yes. So this is this
- 6:26Speaker 1: moment people are falling in love with randomized trials, and
- 6:28Speaker 1: more importantly for our story, Ian Chalmers is realizing that
- 6:33Speaker 1: this evidence is not making its way into medical practice.
- 6:36Speaker 1: What does he do about that?
- 6:38Speaker 2: So he decides to do this pioneering exercise where he
- 6:43Speaker 2: is going to collect all of the controlled clinical trials.
- 6:47Speaker 2: They weren't all randomized, but controlled trials which had been done,
- 6:50Speaker 2: which had tested treatments in pregnancy and childbirth. Okay, and
- 6:55Speaker 2: at the time, so this is in the eighties, I mean,
- 6:57Speaker 2: that was an extraordinarily difficult thing to do because he
- 7:01Speaker 2: couldn't just go online and you know, search up these trials.
- 7:04Speaker 2: So he eventually ended up recruiting hundreds of people to
- 7:08Speaker 2: sort of go to libraries and scour through the medical
- 7:11Speaker 2: journals and really exhaustively try and track down these clinical trials.
- 7:15Speaker 1: It's amazing that it's almost an archaeological exercise, right, like
- 7:19Speaker 1: people have generated all this evidence not in ancient times,
- 7:23Speaker 1: but in the last ten or twenty years, and it's
- 7:25Speaker 1: already been sort of lost. Right. He is an obgyn, right,
- 7:28Speaker 1: and he's having to have people will look for the
- 7:30Speaker 1: research in his field exactly exactly.
- 7:33Speaker 2: It's extraordinary and that is still a real difficult problem today,
- 7:36Speaker 2: which I think is absolutely mind boggling, because a lot
- 7:39Speaker 2: of research is published and yet people still struggle to
- 7:41Speaker 2: find it on databases.
- 7:43Speaker 1: So they're doing this archaeological expedition to look for recent research.
- 7:47Speaker 1: And what happened.
- 7:49Speaker 2: So it takes him about ten years, him and his
- 7:52Speaker 2: many colleagues, and eventually he doesn't just get the evidence together.
- 7:57Speaker 2: I think this is what's so interesting about it is
- 7:59Speaker 2: he realizes that he needs to synthesize the evidence, and
- 8:04Speaker 2: you know, not just to look at one trial at
- 8:06Speaker 2: a time, because if you look at one trial, it
- 8:08Speaker 2: risks being wrong, or you get a group of trials
- 8:11Speaker 2: which may be conflicting, maybe some of them are poorly done,
- 8:14Speaker 2: maybe it's just through chance that they point in different directions.
- 8:17Speaker 2: And so he took this quite radical step of synthesizing
- 8:21Speaker 2: the evidence using a method called a systematic review and
- 8:25Speaker 2: ended up doing hundreds of systematic reviews to look at
- 8:28Speaker 2: all of these different approaches in pregnancy and childbirth and
- 8:33Speaker 2: eventually publishes all of this after ten years in these
- 8:35Speaker 2: two massive books.
- 8:36Speaker 3: Which I also have on my book case following me.
- 8:40Speaker 2: So, they revealed that a lot of practices in pregnancy
- 8:44Speaker 2: and childbirth were not based on evidence or were actually
- 8:47Speaker 2: doing harm. So for example, even things like invasive episiotomies,
- 8:53Speaker 2: which is a surgical incision which is supposed to give
- 8:56Speaker 2: babies a bigger hole to get out, there wasn't really
- 8:59Speaker 2: evidence to support these practices, and like shaving women's pubic
- 9:03Speaker 2: care in labor. So countless women had been subjected to
- 9:06Speaker 2: these really quite invasive and degrading practices because doctors assumed
- 9:10Speaker 2: they were the right thing to do. And Ian's work
- 9:14Speaker 2: by synthesizing evidence in this way helped bring an end
- 9:17Speaker 2: to them. So he was sort of inspired by what
- 9:20Speaker 2: he had done and thought, why can't we do this
- 9:23Speaker 2: across all specialties of medicine, you know, synthesize the evidence
- 9:27Speaker 2: in heart disease and diabetes, in cancer and so on,
- 9:29Speaker 2: And that led to this group which he helped found.
- 9:33Speaker 2: He was seminal in founding called the Cochrane Collaboration, and
- 9:36Speaker 2: they set out and are still trying to do this
- 9:38Speaker 2: today to synthesize evidence which shows which treatments are of
- 9:43Speaker 2: help and do not harm across these different groups. And
- 9:46Speaker 2: nowadays the word sort of like a Cochrane review if
- 9:49Speaker 2: you're here that it's sort of like associated with doing
- 9:53Speaker 2: the kind of highest standard, you know, gold standard type
- 9:56Speaker 2: of review of evidence.
- 9:58Speaker 1: And I would say a lot of it at least
- 10:01Speaker 1: is just online, right, like you can go look if
- 10:04Speaker 1: you're thinking of taking a supplement, say, you can just
- 10:08Speaker 1: go look. And there are a lot of Cochrane reviews
- 10:12Speaker 1: of whatever, magnesium for something something, and I find it useful.
- 10:18Speaker 1: I mean quite often they say there's not enough evidence
- 10:21Speaker 1: to say one way or the other. Right, that's typically
- 10:23Speaker 1: with the kinds of things that I'm looking at, you know,
- 10:26Speaker 1: over the counter things or whatever. There just isn't enough
- 10:29Speaker 1: research to have a clear answer. And that is what
- 10:31Speaker 1: they often say. It makes sense, Yes.
- 10:33Speaker 3: It is often the conclusion.
- 10:34Speaker 2: And I mean it's not just so Cochran reviews now
- 10:37Speaker 2: are a tiny fraction of the number of systematic reviews
- 10:39Speaker 2: in the world. So Cochran was really sort of seminal
- 10:41Speaker 2: in sort of showing that this was a really good
- 10:44Speaker 2: way to make sense of conflicting bodies of evidence. But
- 10:47Speaker 2: now that you know, thousands are coming out every year,
- 10:50Speaker 2: So in general, a systematic review is a better way
- 10:53Speaker 2: to get an overview of what the evidence says than
- 10:55Speaker 2: looking at just one study. Now, of course, it's it's
- 10:58Speaker 2: not completely straightforward because like randomized trials, some systematic reviews
- 11:01Speaker 2: aren't very good either, So that's a challenge too.
- 11:05Speaker 1: Well, it's always something yes, well, I mean that's Cochrane
- 11:08Speaker 1: is useful as a brand in that way, right, Like
- 11:11Speaker 1: I trust their ability to assess the evidence, even if
- 11:15Speaker 1: what they say is we don't know, Like we don't know.
- 11:17Speaker 1: It's a very respectable answer as a general matter. What's
- 11:22Speaker 1: a Charmer's like.
- 11:26Speaker 2: Quite extraordinary actually just the most I don't think I've
- 11:31Speaker 2: ever met anyone who is so extraordinarily modest about his
- 11:34Speaker 2: accomplishments and downplays them so much, to the point where
- 11:37Speaker 2: he denies sort of starting the cock con collaboration. I
- 11:40Speaker 2: think he says something along the lines of he came
- 11:43Speaker 2: up with the idea so and also very exacting and critical.
- 11:49Speaker 2: I mean it was interesting when he retired or decided
- 11:52Speaker 2: to step away. He didn't retire from Cockraney decided he
- 11:54Speaker 2: wanted to move on. He actually set up a prize
- 11:56Speaker 2: for the group that offered the most astute criticism of
- 11:59Speaker 2: the cock Con collaboration.
- 12:00Speaker 1: Oh that's really admirable.
- 12:02Speaker 3: Yes, exactly.
- 12:03Speaker 2: And they still have that attitude of kind of inviting
- 12:05Speaker 2: criticism because of course that's exactly what you know, he
- 12:09Speaker 2: and the group have done all these years is sort
- 12:10Speaker 2: of speak truth to power. So they need to invite
- 12:13Speaker 2: that criticism themselves.
- 12:15Speaker 1: Who won the prize and what did they say?
- 12:19Speaker 2: I don't know, it's one every years.
- 12:22Speaker 1: Yeah, so I could imagine him having a pretty high
- 12:25Speaker 1: tolerance for disagreeableness. Say right, I mean what he did
- 12:30Speaker 1: was in a sort of cultural way in terms of
- 12:34Speaker 1: the culture of physicians, the culture of medicine. I don't know,
- 12:39Speaker 1: antagonistic is maybe too strong a word, but he said
- 12:42Speaker 1: things that presumably lots of people didn't want to hear.
- 12:45Speaker 1: He said, to doctors, you're doing it wrong, both in
- 12:47Speaker 1: a specific way, you shouldn't be doing this particular intervention,
- 12:50Speaker 1: and also in a general way, like he implicitly or
- 12:53Speaker 1: explicitly was saying you're thinking about the practice of medicine wrong.
- 12:57Speaker 2: That's right, that's exactly right. I discovered this as I
- 13:00Speaker 2: sort of was reporting the book and kind of speaking
- 13:03Speaker 2: to these people who were quite seminal in bringing evidence
- 13:07Speaker 2: based practice into their fields. They often have this sort
- 13:09Speaker 2: of rebellious streak to them and are kind of willing
- 13:12Speaker 2: to speak truth to power, because yes, it does. I mean,
- 13:14Speaker 2: you're basically saying to people, you know, ort to doctors,
- 13:17Speaker 2: you've been doing it wrong all these years. And he
- 13:21Speaker 2: himself said he thought he was able to do that
- 13:23Speaker 2: because he was sort of he was a bit of
- 13:25Speaker 2: an outsider actually, Like he worked in Oxford, but he
- 13:29Speaker 2: wasn't sort of part of all the kind of you know,
- 13:31Speaker 2: high for lutin academic circles. He was a bit on
- 13:35Speaker 2: the outside and he felt that that allowed him to
- 13:37Speaker 2: maybe do this speaking of truth to power, which maybe
- 13:42Speaker 2: others what unable to do.
- 13:43Speaker 1: So where's medicine today? To what extent is medicine today
- 13:47Speaker 1: evidence based?
- 13:49Speaker 2: Well more than it was then. I think I used
- 13:54Speaker 2: a figure in my book of about sort of sixty
- 13:56Speaker 2: percent of healthcare is probably evidence based or at least
- 14:02Speaker 2: draws on evidence based clinical guidelines. So nowadays what happens
- 14:05Speaker 2: is there are typically systematic reviews of clinical trials or
- 14:10Speaker 2: are the evidence, and on the back of that, then
- 14:13Speaker 2: professional groups prepare clinical guidelines and the clinical guidelines of
- 14:16Speaker 2: what might be used in the clinic to help actually
- 14:18Speaker 2: make a decision.
- 14:19Speaker 1: Right, so, like the National Association of Cardiologists will have
- 14:23Speaker 1: guidelines on whatever who should get statins or who should
- 14:26Speaker 1: get what interventions exactly.
- 14:28Speaker 2: And that, I mean, that's quite interesting because it means
- 14:30Speaker 2: that the evidence is kind of baked into the processes,
- 14:33Speaker 2: which which I find quite interesting. It's sort of made it.
- 14:36Speaker 2: I mean, I won't say it's easy, but it is
- 14:37Speaker 2: relatively easy for doctors now to use evidence because that's
- 14:40Speaker 2: the expectation. Whereas I'm sure we'll get onto this, but
- 14:42Speaker 2: you look at other fields and that's just not the case.
- 14:45Speaker 2: But of course there are huge challenges, you know, lots
- 14:47Speaker 2: of criticism still of evidence based medicine. Some people criticize,
- 14:51Speaker 2: for example, you know, this sort of special place that
- 14:54Speaker 2: the randomized control trial has and point out that randomized
- 14:57Speaker 2: control trials can be wrong or poorly done. And then
- 15:00Speaker 2: of course, you know, pushback in the world against evidence
- 15:03Speaker 2: based practices. Anyway, and people wanting to go their own way. So,
- 15:07Speaker 2: in no way is the kind of evidence revolution that
- 15:10Speaker 2: I write about, you know, obviously done.
- 15:12Speaker 3: It's evolving, it's new in some way.
- 15:16Speaker 1: So if you say it's sixty percent evidence based for
- 15:18Speaker 1: the other forty, I could imagine two things. Right Clearly,
- 15:22Speaker 1: there are a lot of settings, Like medicine is complicated.
- 15:24Speaker 1: People are complicated, the body is complicated, lots of sick
- 15:27Speaker 1: people have lots of things wrong with them. So you
- 15:29Speaker 1: can imagine lots of cases where there just isn't evidence,
- 15:32Speaker 1: where it's just not clear what should I do for
- 15:33Speaker 1: this patient right now? Well, there's lots of different conflicting
- 15:36Speaker 1: things that I could do in their trade offs. The
- 15:38Speaker 1: other piece is there is evidence and people just don't
- 15:42Speaker 1: follow it. So like how much of each of those
- 15:45Speaker 1: is there?
- 15:46Speaker 2: Yeah, so I can't give you a percentage on each
- 15:47Speaker 2: of those. But I mean, just to speak to the
- 15:49Speaker 2: first one though, I mean, what's really interesting about evidence
- 15:52Speaker 2: based medicine is that evidence alone doesn't tell you what
- 15:55Speaker 2: to do. So evidence is one part of the decision
- 15:59Speaker 2: making process, and I think that's a common misunderstanding actually
- 16:02Speaker 2: around it is that like you look at the evidence
- 16:04Speaker 2: and it will tell you, you know, whether you should take
- 16:05Speaker 2: this drug. But that's not the case because what what
- 16:08Speaker 2: a doctor or who whoever is you know, a doctor,
- 16:10Speaker 2: hopefully impatient together are doing is saying, Okay, you know,
- 16:12Speaker 2: this is the evidence on what treatments are effective. This
- 16:15Speaker 2: is the clinical expertise of the doctor who absolutely you know,
- 16:18Speaker 2: they've built up all this expertise over the years. We're
- 16:21Speaker 2: not throwing that out the window. And then you as
- 16:23Speaker 2: a patient have values and preferences which have to feed
- 16:26Speaker 2: into this decision. Right, if you've decided this isn't a
- 16:29Speaker 2: treatment path you want, then that has to be respected. So,
- 16:32Speaker 2: but that's still evidence based.
- 16:33Speaker 1: Medicine, and that's still in your sixty percent easy one. Yeah, yeah,
- 16:37Speaker 1: Like tell me about the forty percent that's not evidence based.
- 16:39Speaker 1: What is what's going on there?
- 16:41Speaker 2: Well, in some places, evidence based medicine is less common
- 16:45Speaker 2: or accepted, so people might choose traditional Chinese medicine, for example,
- 16:50Speaker 2: So there may be other practices around medicine which people prefer.
- 16:54Speaker 2: In some cases, You're absolutely right, the evidence isn't really
- 16:58Speaker 2: there or it might be misapplied. So there's the kind
- 17:01Speaker 2: of all the human factors that come into it where
- 17:04Speaker 2: people may do choice or inadvertently not follow the evidence.
- 17:09Speaker 3: Ice Pak.
- 17:13Speaker 1: Will be back in just a minute. Okay, So let's
- 17:28Speaker 1: talk about evidence outside of medicine. A big chunk of
- 17:31Speaker 1: your book is that, And it does seem to some
- 17:35Speaker 1: extent at least, that this evidence based revolution, as you
- 17:39Speaker 1: call it, that Ian Chalmers helped us start, has directly
- 17:43Speaker 1: influenced people in other fields. You know, and you write
- 17:47Speaker 1: about economics and crime and management and parenting, and you know,
- 17:55Speaker 1: I will say, like I covered economics for a long time,
- 17:58Speaker 1: and in economics they've gotten better about evidence. It seems
- 18:01Speaker 1: to me that in a lot of fields outside of medicine,
- 18:05Speaker 1: it's just frustrating. It's just frustrating when you sort of
- 18:08Speaker 1: try and study the evidence. It seems like there's often
- 18:10Speaker 1: not good evidence. When there is, people don't follow the evidence.
- 18:13Speaker 1: I mean, in a broad way, what's your assessment of
- 18:16Speaker 1: how evidence as a way of looking at the world
- 18:19Speaker 1: is doing outside of medicine.
- 18:21Speaker 2: So I think it really depends which field you're looking
- 18:24Speaker 2: in of how like I suppose I ended up thinking
- 18:28Speaker 2: that each of these fields was, you know, weaving its
- 18:31Speaker 2: own path through evidence, and some of them had directly
- 18:33Speaker 2: looked at medicine and gone, yeah, we want to do
- 18:35Speaker 2: that too. We should think our practices shouldn't be based
- 18:38Speaker 2: on conventional wisdom an anecdote. And in others, like in
- 18:42Speaker 2: economics example, there's kind of you know, evidences that the
- 18:45Speaker 2: use of randomized trials has really swept through international development,
- 18:48Speaker 2: through development economics. But yeah, I think I don't think
- 18:51Speaker 2: any of them have advanced as far as medicine. And
- 18:54Speaker 2: I think that that is partly because of the histories
- 19:00Speaker 2: of the of these fields and the people who've been
- 19:03Speaker 2: championing it, and the different barriers that it's faced.
- 19:05Speaker 1: It seems harder in most other domains to do useful
- 19:12Speaker 1: you know, studies that have real external validity where you
- 19:16Speaker 1: can look at something in one place and say this
- 19:18Speaker 1: same intervention is going to work in other places, Like
- 19:20Speaker 1: the world is messy, is a fundamental problem with trying
- 19:24Speaker 1: to generate evidence.
- 19:25Speaker 2: Yeah, it makes things really really hard. So let's say
- 19:28Speaker 2: you want to, I don't know, you know, test whether
- 19:31Speaker 2: giving people incentives to have vaccines works. And I mean
- 19:35Speaker 2: I talked about a trial in the book that was
- 19:37Speaker 2: done where in India people were offered steel dinner plates
- 19:42Speaker 2: and bags of lentils in order to incentivize parents to
- 19:45Speaker 2: compliclents had their children vaccinated, and it seemed to be effective.
- 19:47Speaker 2: Right now, you can't just lift and shift that and
- 19:50Speaker 2: put it into you know, the UK. You know, you
- 19:52Speaker 2: have to think about the different cultures and you know,
- 19:55Speaker 2: the different ways incentives might work, and so on and
- 19:57Speaker 2: so forth.
- 19:58Speaker 1: I mean that particular example, like you do see conditional
- 20:01Speaker 1: cash transfers in other countries where you know, if parents
- 20:04Speaker 1: bring their children for vaccination and send them to school,
- 20:07Speaker 1: then they get a monthly stipend from the government. Like
- 20:11Speaker 1: those seem to work, Like those that one does seem
- 20:14Speaker 1: to generalize at least.
- 20:15Speaker 3: Some yes, it has. I mean that's built up.
- 20:18Speaker 2: That's unusual really and having such a body of evidence
- 20:20Speaker 2: to it, that's built up over time.
- 20:22Speaker 1: Although it's funny like that one, I understand that we
- 20:24Speaker 1: shouldn't rely on common sense is one of the themes
- 20:27Speaker 1: of the book. But like, if you give people money
- 20:29Speaker 1: to do something that is actually helpful to them, they
- 20:31Speaker 1: will do it. Is basically what that finding says, and
- 20:35Speaker 1: it's true.
- 20:36Speaker 2: Right, but it took evidence to convince policymakers of that. Yeah, fair,
- 20:40Speaker 2: So the counter argument, you know, You're absolutely right that
- 20:43Speaker 2: this point about generalization is like a really big problem
- 20:46Speaker 2: across all of these fields, right that what works in
- 20:48Speaker 2: one place might not work in another. Now, some people
- 20:51Speaker 2: would say, well why bother? You know, well why bother
- 20:53Speaker 2: getting evidence at all? Like what's the point of testing it?
- 20:56Speaker 2: But you generally, over time, you know, if something it
- 21:01Speaker 2: might not work exactly the same. But if you start
- 21:03Speaker 2: to build up a body of evidence that shows, yeah,
- 21:05Speaker 2: actually this seems to like the conditional cash transfers have
- 21:08Speaker 2: some effectiveness here and some effectiveness here, then you've come
- 21:11Speaker 2: up with a robust policy that does seem worth pursuing.
- 21:15Speaker 1: Tell me about evidence based policy making for like government policy,
- 21:19Speaker 1: social policy, like what how has the sort of march
- 21:22Speaker 1: of evidence been there?
- 21:25Speaker 2: So I think in line I concluded in the end
- 21:29Speaker 2: that there was a kind of what I call the
- 21:30Speaker 2: evidence zeitgeist around the sort of nineteen nineties to maybe
- 21:34Speaker 2: twenty ten, when a lot of these fields were turning
- 21:37Speaker 2: to evidence. And I think it's because these ideas of
- 21:40Speaker 2: evidence based medicine were percolating out and people were coming
- 21:43Speaker 2: across them, and then you see this kind of emerge
- 21:45Speaker 2: in the policy language. So you know, we had for example,
- 21:49Speaker 2: Tony Blair and New Labor were talking about evidence based policy,
- 21:53Speaker 2: or doing what works as it was called, in the
- 21:55Speaker 2: nineteen nineties. Obama talked about it in his inauguration speech
- 22:00Speaker 2: in two thousand and nine. So it sort of was
- 22:02Speaker 2: filtering into policy, and you know, particular people became very
- 22:07Speaker 2: enamored by it, I would say it sort of it
- 22:10Speaker 2: succeeded in certain pockets, shall we say.
- 22:13Speaker 1: And during that time people are championing it. Are you
- 22:17Speaker 1: seeing policy changes based on evidence? Are they actually doing
- 22:21Speaker 1: the thing they're talking about?
- 22:23Speaker 2: In some cases there were yes. So that there was
- 22:26Speaker 2: a series of what were called, for example, in the
- 22:28Speaker 2: Obama in administration, a series of what were called tiered
- 22:31Speaker 2: evidence initiatives which came in where in order for policy
- 22:35Speaker 2: to progress, it was only allowed to, for example, have
- 22:38Speaker 2: extra funding if it was able to produce evidence of effectiveness.
- 22:42Speaker 1: Are there examples of things that got cut because they
- 22:44Speaker 1: were sort of proven to not work? That's the real one,
- 22:48Speaker 1: right Are you going to say, hey, this doesn't work,
- 22:50Speaker 1: so we're going to stop doing it.
- 22:51Speaker 2: That is much harder to find examples of, I would say, yeah, yeah.
- 22:55Speaker 1: So what are examples of things that got funded because
- 22:58Speaker 1: there was evidence that they were good.
- 23:00Speaker 2: One example was the Nurse Family Partnership, which is a
- 23:03Speaker 2: program where first time mothers are given a lot of
- 23:07Speaker 2: support in the you know, the early time of pregnancy
- 23:10Speaker 2: and in the first two years of life. And because
- 23:12Speaker 2: there was a lot of evidence that this really was
- 23:15Speaker 2: helpful towards child outcomes, that progressed and was awarded more
- 23:20Speaker 2: government funding.
- 23:21Speaker 1: And what's the status of that program now?
- 23:24Speaker 3: Still going?
- 23:25Speaker 1: I'm still going. I didn't expect that, I'll admit, in
- 23:28Speaker 1: my jade at heart, I thought you were going to
- 23:30Speaker 1: tell me it got killed. That's in the US. Yep, Okay,
- 23:35Speaker 1: well that's good news. Tell me about you have a
- 23:40Speaker 1: chapter about evidence based management. The evidence seems particularly weak
- 23:47Speaker 1: in that domain.
- 23:48Speaker 2: Frankly, I think some of the evidence is weak, and
- 23:52Speaker 2: I think the culture of using evidence is very weak.
- 23:56Speaker 2: So of the fields I looked at, I would say
- 23:58Speaker 2: that that is the one where I felt evidence was
- 24:01Speaker 2: struggling the most. I mean, there is a surprising amount
- 24:05Speaker 2: of evidence on effective management practices, and a lot of
- 24:09Speaker 2: people are kind of really sort of surprised to discover this.
- 24:11Speaker 2: Like you can, you know, find doctors who are absolutely
- 24:14Speaker 2: evidence based and everything they do, but they think that
- 24:16Speaker 2: maybe management is some type of you know, magic or
- 24:19Speaker 2: art or something. So yeah, there's evidence on you know,
- 24:23Speaker 2: whether feedback works, or you know, whether the performance appraisals work,
- 24:27Speaker 2: which by the way, they don't seem to be all
- 24:29Speaker 2: that effective, but improving performance, which I found quite interesting.
- 24:32Speaker 1: Yes, I'm overdue that the performance appraisal software keeps bothering
- 24:38Speaker 1: me that I'm overdu So if you're telling me it's
- 24:40Speaker 1: a waste of time, you're validating my behavior, and I'm
- 24:43Speaker 1: happy to hear it. So what does work? Tell me?
- 24:46Speaker 1: Like one management thing where there's like really clear evidence
- 24:50Speaker 1: that is actually actionable to use a management word, that's like,
- 24:56Speaker 1: here's a great thing, and you should do it if
- 24:58Speaker 1: you're a manager.
- 24:59Speaker 2: So goal setting is very effective and good good feedback,
- 25:04Speaker 2: good feedback meaning fair feedback, feedback which is specific to people,
- 25:11Speaker 2: you know, not generic feedback. So there does seem to
- 25:14Speaker 2: be good evidence that those things are effective at improving
- 25:17Speaker 2: performance fair enough.
- 25:19Speaker 1: Why do I find that unsatisfying? Maybe because it seems obvious.
- 25:23Speaker 2: Yes, it seems of no, but that's a really good point.
- 25:26Speaker 2: So that to me is one of the things that
- 25:28Speaker 2: holds back evidence based management because some of the principles
- 25:31Speaker 2: which are supported by evidence feel obvious to people and
- 25:34Speaker 2: they're not new, and what sales business book is exciting
- 25:38Speaker 2: new ideas which aren't necessarily tested or proven to work,
- 25:43Speaker 2: So there's financial incentive sort of working against evidence based management.
- 25:47Speaker 3: In my view.
- 25:48Speaker 1: You've been an editor and a writer on the sort
- 25:50Speaker 1: of magazine side of the journal nature, right, And I
- 25:54Speaker 1: was a newspaper reporter before. And I mean I was
- 25:57Speaker 1: thinking about evidence in our profession, right. And I don't
- 26:01Speaker 1: mean evidence in the sense of like you want to
- 26:03Speaker 1: write about what's true, or you want to assess the
- 26:05Speaker 1: evidence when you're writing about something. I mean evidence for
- 26:08Speaker 1: the way one should write, or what kinds of stories
- 26:11Speaker 1: we should do, or what headlines we should write. And
- 26:15Speaker 1: in my career there has been none of that essentially.
- 26:17Speaker 1: I mean, you had the Internet come along. I'm old
- 26:19Speaker 1: enough that I remember when that was relatively new and people,
- 26:22Speaker 1: you know, you had a dashboard and you started to see, oh,
- 26:25Speaker 1: people are reading these kinds of stories and not reading
- 26:27Speaker 1: those kinds of stories, and in a sort of quasi
- 26:29Speaker 1: anecdotal way, you might shift course. But nobody wanted to
- 26:35Speaker 1: use evidence. I mean, not only did people really not
- 26:37Speaker 1: think that way, but to the extent they did, they
- 26:40Speaker 1: didn't want to think that way, right, Like we like
- 26:42Speaker 1: writing the kinds of stories we write. I learned some
- 26:44Speaker 1: particular craft of podcasting that was, like one guy who
- 26:48Speaker 1: was really good at making podcasts, we thought, told everybody
- 26:51Speaker 1: how to do it, and we did it right, imminence
- 26:52Speaker 1: based podcasting. And then all these other podcasts come along
- 26:56Speaker 1: that are nothing like the rules that I learned and
- 26:59Speaker 1: are wildly popular, and I'm like, oh, the rules that
- 27:01Speaker 1: I learned were just what one guy made up and
- 27:03Speaker 1: we all liked. But I haven't really changed much based
- 27:08Speaker 1: on that. I mean, do you use evidence in your craft?
- 27:14Speaker 3: That's such a good question.
- 27:16Speaker 2: I mean, really, what you're talking about is using data
- 27:19Speaker 2: right to inform what you do.
- 27:22Speaker 1: I think, well, you could do a randomized control trial.
- 27:26Speaker 1: I mean, certainly a B testing of health AB test
- 27:28Speaker 1: is the thing people do, yes, exactly, but you could
- 27:31Speaker 1: do You could do a randomized trial of different kinds
- 27:35Speaker 1: of articles in nature if you want it right, you
- 27:37Speaker 1: could random You could prospectively decide we're going to randomly
- 27:41Speaker 1: assign somebody to do A or B or whatever. As
- 27:44Speaker 1: far as I know, nobody's ever done that.
- 27:47Speaker 3: That's a great point. Yep.
- 27:48Speaker 2: Absolutely, yeah, Mostly people are chasing audiences.
- 27:52Speaker 1: But even analyzing the best way to chase audiences, like
- 27:56Speaker 1: why don't we do that?
- 27:57Speaker 3: We should, let's do it.
- 28:00Speaker 1: But do you mean that? I feel like I don't
- 28:02Speaker 1: wanna at some level? Right, this is like part of
- 28:05Speaker 1: the It's like I like doing my job the way
- 28:07Speaker 1: I want to like. Yes, I also would like to
- 28:10Speaker 1: have more listeners. And perhaps if I was better, you know,
- 28:12Speaker 1: more analytical or more evidence based, I would have more listeners.
- 28:16Speaker 1: But I don't know. I think there's something going on
- 28:18Speaker 1: there that is interesting and that points to resistance to evidence.
- 28:22Speaker 1: Like I think of myself as an analytical person. I
- 28:24Speaker 1: think I follow evidence in healthcare, and yet in this
- 28:26Speaker 1: thing I do all day every day, I sort of
- 28:28Speaker 1: don't pay attention.
- 28:30Speaker 2: Well, it depends what outcome you want, right, I mean,
- 28:32Speaker 2: if your outcome is very clearly that you want to
- 28:34Speaker 2: grow listeners, then you might be incentivized and to do
- 28:38Speaker 2: that experiment. If you're happy with the outcome and no
- 28:40Speaker 2: one's being harmed by which I don't think they are,
- 28:42Speaker 2: if you continue to podcast in the way you do,
- 28:44Speaker 2: or I tell stories in the way that I do.
- 28:46Speaker 2: Then you know there has to be an incentive, I
- 28:49Speaker 2: think to do the test.
- 28:51Speaker 1: How did writing the book change the way you think
- 28:53Speaker 1: about evidence?
- 28:56Speaker 2: I think it changed the way I work as a
- 28:59Speaker 2: journalist to some extent. I mean, obviously, I write features
- 29:03Speaker 2: about complex bodies of evidence, so I find interesting questions
- 29:06Speaker 2: and I want to go and look at what the
- 29:07Speaker 2: evidence says about them. And I would say, what's changed
- 29:10Speaker 2: about that is I am much more likely to now
- 29:13Speaker 2: look for evidence synthesies, so for example, for systematic reviews
- 29:17Speaker 2: when I'm diving into a new field, and I don't
- 29:19Speaker 2: think I did that as much in the past, and
- 29:21Speaker 2: I found that quite liberating, you know, because and of
- 29:24Speaker 2: course evidence is just ballooning, I mean in terms of
- 29:26Speaker 2: the amount of a search that's coming out. So that's
- 29:28Speaker 2: been quite helpful.
- 29:30Speaker 3: I mean.
- 29:30Speaker 1: The classic bread and butter of science journalism is writing
- 29:33Speaker 1: about a new study, right, But one lesson of what
- 29:35Speaker 1: you're talking about is like, except in rare cases where
- 29:39Speaker 1: the new study is like really giant or something, we
- 29:43Speaker 1: should almost ignore new studies, Like we should add this
- 29:46Speaker 1: one new study to this part of a thousand studies
- 29:49Speaker 1: and see how much it, you know, adjusts the totality
- 29:52Speaker 1: of the evidence, which is usually going to be not
- 29:54Speaker 1: that much, right, Yes.
- 29:56Speaker 2: I mean it's going to depend how big the body
- 29:57Speaker 2: of evidence is that you're adding the study to.
- 29:59Speaker 1: So you're right.
- 30:00Speaker 2: If it's a brand new trial it's the first time
- 30:02Speaker 2: it's tested a drug, totally we should write about that,
- 30:04Speaker 2: reports on it. But if it's another trial, another study
- 30:07Speaker 2: saying you know, wine is good for you, that's probably
- 30:11Speaker 2: best to put to one time.
- 30:12Speaker 1: Now.
- 30:12Speaker 2: The reason, of course those stories still come out is
- 30:15Speaker 2: because they get clicks on websites.
- 30:18Speaker 3: But I'm with you.
- 30:19Speaker 2: I mean I have definitely reached this point of thinking, yes,
- 30:22Speaker 2: I need to look at the body of evidence as
- 30:23Speaker 2: a whole.
- 30:24Speaker 1: And what about outside of science, Like do you use
- 30:32Speaker 1: Is there any part of your life where you use
- 30:34Speaker 1: evidence now outside of work, outside of health where you
- 30:38Speaker 1: didn't use it before?
- 30:40Speaker 2: Well, probably I use it more in parenting. I mean,
- 30:44Speaker 2: that's a really interesting case where I feel it's a
- 30:48Speaker 2: bit like management in that there's just it's completely a
- 30:53Speaker 2: wash with you know, fads and fashions and books and
- 30:56Speaker 2: actually there is quite a lot of evidence around, you know,
- 30:59Speaker 2: practices that can support child developments. Some of which is
- 31:02Speaker 2: mirrored in standard parenting advice, but some of which might
- 31:04Speaker 2: be slightly different, And I just think it gets lost
- 31:06Speaker 2: in the kind of fire hose of information.
- 31:09Speaker 1: That's a non obvious piece of parenting advice with robust
- 31:12Speaker 1: evidence behind it.
- 31:13Speaker 2: I don't know if it's not obvious, I would just
- 31:14Speaker 2: say it's obviously a really live debate right around. I've
- 31:18Speaker 2: looked specifically for nature. The evidence around is social media
- 31:23Speaker 2: and screen news causing the rise in mental health problems
- 31:29Speaker 2: for adolescents and young people. And that is a really
- 31:33Speaker 2: complicated body of evidence, which I think people are interpreting
- 31:36Speaker 2: in different ways. But I do think that this general
- 31:40Speaker 2: sense that that's been shown that this is causative and
- 31:43Speaker 2: it's a huge driver of adolescent mental health problems is
- 31:47Speaker 2: an overreach based on the people that I've spoken to
- 31:50Speaker 2: and having looked at the evidence myself.
- 31:53Speaker 1: So are you saying screens and social media aren't as
- 31:56Speaker 1: bad for teenagers as a lot of people think. Is
- 31:58Speaker 1: that a fair reduction of what you said?
- 32:00Speaker 3: Yeah?
- 32:01Speaker 1: Yeah, yeah, good news, good news.
- 32:03Speaker 2: Can I go back to your point, because you asked
- 32:05Speaker 2: me how it's changed, how I are you know, personal decisions.
- 32:08Speaker 1: You elect your kids stay the phones more than you
- 32:10Speaker 1: did before.
- 32:12Speaker 2: To some extent, yeah, I mean it just made me
- 32:14Speaker 2: relax a little bit about it, because you know, we're
- 32:17Speaker 2: really seeking these concrete answers, aren't we. Or what I
- 32:20Speaker 2: would have loved the evidence to say was like, you know,
- 32:23Speaker 2: two hours and that's it, right, But it doesn't. It
- 32:26Speaker 2: doesn't provide you with simple answers. Evidence generally doesn't. But
- 32:29Speaker 2: sometimes I think that that can be quite empowering itself,
- 32:33Speaker 2: you know, as a parent, to go, Okay, well, I
- 32:34Speaker 2: have looked at the evidence and it doesn't give me
- 32:36Speaker 2: the crisp answers I would really love to have about
- 32:38Speaker 2: what to do. But I understand that, and now I
- 32:41Speaker 2: feel empowered to perhaps make decisions on my own based
- 32:45Speaker 2: on my common sense and weighing up the things which
- 32:47Speaker 2: are important to me and my family.
- 32:50Speaker 1: What's the future of evidence as a as an idea
- 32:53Speaker 1: evidence in the world, Like, do you feel like we're
- 32:56Speaker 1: in this moment when there's a sort of evidence backlash.
- 32:59Speaker 2: To some extent, I literally published a big piece last
- 33:02Speaker 2: week for Nature about trust in science because I wanted
- 33:05Speaker 2: to look at this kind of They're like, there's a
- 33:06Speaker 2: sort of sense in the air that there's this like
- 33:10Speaker 2: big crisis of trust in science. People have lost trust
- 33:12Speaker 2: in science, and I wanted to kind of scrutinize that claim,
- 33:15Speaker 2: So I went off and looked at kind of data,
- 33:16Speaker 2: and I've spoken to lots of people, and I would
- 33:18Speaker 2: say the big picture, given that surveys are imperfect, but
- 33:22Speaker 2: from lots of surveys, is that generally, you know, globally,
- 33:26Speaker 2: trust in science is quite high. People generally trust science,
- 33:30Speaker 2: and scientists as a profession is one of the most
- 33:32Speaker 2: trusted professions. Like it's up there with like doctors and teachers,
- 33:35Speaker 2: you know, and you've got journalists like me and politicians
- 33:38Speaker 2: who go down the bottom of the list. So the
- 33:41Speaker 2: global picture is kind of like glassharlf full. Everything looks fine,
- 33:44Speaker 2: but then obviously they yes, they were a big problems.
- 33:46Speaker 2: So in the US, trust in science has gone down
- 33:50Speaker 2: in the last few years, and there's a specifically a
- 33:53Speaker 2: political polarization going on around trust in science in the US,
- 33:57Speaker 2: with it falling amongst Republican leaning people but remaining high
- 34:01Speaker 2: amongst Democrats, and people feel concerned that the Trump administration
- 34:06Speaker 2: is kind of capitalizing on this idea of distrust of
- 34:10Speaker 2: science to now attack scientific institutions. So I don't want
- 34:13Speaker 2: to give the impression that I came away from this
- 34:15Speaker 2: exercise thinking everything's rosy with trust in science.
- 34:18Speaker 3: Because that's not the case.
- 34:19Speaker 2: This big global trust in Science survey I looked at
- 34:22Speaker 2: in some countries lower trust in science was associated with
- 34:26Speaker 2: being right leaning, but in others it was associated with
- 34:28Speaker 2: being left leaning. So it really kind of depends on
- 34:31Speaker 2: the country.
- 34:32Speaker 1: What's the future of evidence?
- 34:34Speaker 2: I think in some ways, you know, looking at the
- 34:37Speaker 2: evidence revolution, like going back to where we started, it's
- 34:40Speaker 2: quite recent, you know. I mean, evidence based medicine as
- 34:43Speaker 2: a term was only introduced in nineteen ninety one, thirty
- 34:46Speaker 2: five years ago. So if you want to have the
- 34:48Speaker 2: optimistic view, which maybe I do, you know, you could
- 34:51Speaker 2: say that the current kind of setbacks are that there's
- 34:54Speaker 2: always been opposition to evidence, and what's happening now is
- 34:58Speaker 2: just another setback in the kind of longer march towards rationality,
- 35:02Speaker 2: which is going to take decades. So I suppose, yeah,
- 35:05Speaker 2: I do come out hoping that's the case. It feels
- 35:07Speaker 2: a little hard for me to believe that we're going
- 35:10Speaker 2: to get to a point where we reject all of
- 35:13Speaker 2: this knowledge we've created in the world and choose not
- 35:15Speaker 2: to use that at all in decisions.
- 35:18Speaker 3: I hope that we don't get to that point.
- 35:24Speaker 1: We'll be back in a minute with the lightning round.
- 35:37Speaker 1: Let's finish with the lightning round if you would. Okay,
- 35:42Speaker 1: what's a piece of really solid evidence that you ignore?
- 35:46Speaker 3: Oh?
- 35:48Speaker 2: I think I try not to think too hard about
- 35:52Speaker 2: the evidence on alcohol, even though I've written a whole
- 35:58Speaker 2: piece about it, because I know having reported on it,
- 36:03Speaker 2: and I literally like calculated it all out and looked
- 36:05Speaker 2: at my own drinking and I thought, hmm, I probably
- 36:08Speaker 2: should less, and I find it difficult to do that.
- 36:11Speaker 2: I'm not saying I drink to excess. I'm just saying
- 36:13Speaker 2: it probably should be less than it is.
- 36:14Speaker 1: Well, the old like one glass of wine a day
- 36:17Speaker 1: is actually good for you. The evidence seems to have
- 36:20Speaker 1: shifted on that on that claim. Correct.
- 36:23Speaker 2: Yes, in general, most people could benefit by cutting back,
- 36:26Speaker 2: and the risks go up from a really low level.
- 36:29Speaker 1: Yeah, And was the problem with that evidence confounding that
- 36:33Speaker 1: the people who drink one glass of wine a day
- 36:35Speaker 1: tend to be have really healthy lives. They're like very
- 36:38Speaker 1: moderate people. They don't do anything in excess and that's
- 36:41Speaker 1: why it looked like that was good for you.
- 36:43Speaker 2: Partly, yes, confounding is really hard to ship out at
- 36:46Speaker 2: those studies, and also, of course the other ways that
- 36:48Speaker 2: heavy drinkers also tend to be smokers and do all
- 36:50Speaker 2: the other unhealthy behaviors, So it is.
- 36:52Speaker 3: It is a difficult relationship to tease out.
- 36:57Speaker 1: So you previously wrote a book about these longitudinal studies
- 37:01Speaker 1: right where researchers, as I understand it, followed a group
- 37:05Speaker 1: of people for their entire lives extremely interesting. What were
- 37:10Speaker 1: some of the things they learned from those studies?
- 37:13Speaker 2: The big message from all of the studies, I mean,
- 37:14Speaker 2: I set off to write this book that I thought
- 37:16Speaker 2: was going to be about these fascinating sort of about
- 37:19Speaker 2: science somehow, and I sort of ended up writing this
- 37:22Speaker 2: book about inequality, which I didn't really realize till i'd
- 37:25Speaker 2: published it, because really the big message was that children
- 37:28Speaker 2: who were born into difficult circumstances tend to follow on average,
- 37:32Speaker 2: tend to follow more difficult life paths, so they ended
- 37:35Speaker 2: up in poorer health, less wealth, in less good jobs.
- 37:39Speaker 2: And maybe that sounds really obvious, but the sad thing
- 37:41Speaker 2: is that that's kind of been repeated generation after generation
- 37:44Speaker 2: and it's still being repeated today.
- 37:46Speaker 1: Huh, So mobility didn't significantly increase over time.
- 37:52Speaker 2: Not no, I mean there has been some changes, But
- 37:56Speaker 2: that point about your early circumstances having this profound influence
- 38:00Speaker 2: on the rest of your life that remains true.
- 38:04Speaker 1: Tell me about beer glasses in British pubs.
- 38:11Speaker 3: I love this story.
- 38:13Speaker 2: This is one of my favorite randomized trials that I
- 38:15Speaker 2: came across when I was writing the book. So this
- 38:18Speaker 2: is a story about a highly unlikely trial that was
- 38:23Speaker 2: done by a researcher called Jonathan Shepherd, who is still
- 38:28Speaker 2: actually a facial surgeon, and he noticed that a lot
- 38:31Speaker 2: of the people that he was treating with terrible injuries
- 38:34Speaker 2: had come from glass. Often these awful incidents where people
- 38:37Speaker 2: were glassings, where two people in a pub get angry
- 38:40Speaker 2: and somebody decides to shove what's in their hand, which
- 38:44Speaker 2: is like their pint glass, into somebody else's face, and
- 38:46Speaker 2: so they have these awful lacerations and life altering injuries.
- 38:50Speaker 2: And so he started thinking, well, what if we had
- 38:53Speaker 2: stronger beer glasses and maybe that would lead to less
- 38:56Speaker 2: glass injuries.
- 38:58Speaker 1: Just to be clear, why is it better if if
- 39:00Speaker 1: that pub, if that glass that they're shoving into somebody's
- 39:03Speaker 1: face is tougher, it's less likely to shutter to shadow.
- 39:07Speaker 2: So basically you might have been part of this unusual
- 39:09Speaker 2: randomized trial of beer glasses if you bought a pint
- 39:12Speaker 2: in a selection of pubs in the UK and Wales
- 39:16Speaker 2: around nineteen ninety eight. Because he got a selection of
- 39:19Speaker 2: pubs and bars to randomly, some of them were signed
- 39:24Speaker 2: to install toughened glasses and the rest carried on with
- 39:28Speaker 2: their normal glasses and managed to show it was a
- 39:31Speaker 2: bit of a complicated trail, but he managed to show
- 39:33Speaker 2: that indeed, having tougher glass reduced the number of glass injuries,
- 39:37Speaker 2: and this helped lead to momentum which encouraged the pub
- 39:40Speaker 2: industry to switch to toughened glass in the UK, leading
- 39:44Speaker 2: to or least associated with a drop in a glass injuries.
- 39:49Speaker 1: Of like tens of thousands a year or something extraordinary
- 39:53Speaker 1: big number.
- 39:53Speaker 3: Yeah, yeah, amazing.
- 39:55Speaker 1: Somebody gave you, say, one hundred million dollars to fund
- 39:59Speaker 1: a study, any study you want. What would you do?
- 40:04Speaker 3: Wow?
- 40:06Speaker 2: Oh my god, Okay, that's that's I'm trying to think
- 40:10Speaker 2: of the question that I most want an answer to
- 40:12Speaker 2: for which there is no evidence. It has to be
- 40:14Speaker 2: something around parenting. I mean, okay, I'll give you an answer,
- 40:19Speaker 2: but I think it's a bit of a cheat because
- 40:23Speaker 2: it's sort of happening, which is around these social media
- 40:27Speaker 2: bans which are going on at the moment. I mean,
- 40:29Speaker 2: the UK is just introducing a policy to ban all
- 40:32Speaker 2: teenagers from social media, and it's already happened in Australia.
- 40:35Speaker 2: So I think the key, the key question, which evidence
- 40:38Speaker 2: curious people like me have and lots of researchers have,
- 40:41Speaker 2: is what's the effect. So I think a careful study
- 40:44Speaker 2: to understand the impact of those changes is really important.
- 40:49Speaker 1: It was great to speak with you, and I appreciate
- 40:53Speaker 1: your work.
- 40:53Speaker 3: Thank you, Thank you very much.
- 40:55Speaker 2: No, thanks very much for your questions and thanks for
- 40:56Speaker 2: having me on the show.
- 41:04Speaker 1: Helen Pearson is the author of the book Beyond Belief.
- 41:07Speaker 1: Please email us at problem at pushkin dot fm. Tell
- 41:11Speaker 1: us what kinds of shows we should do more of
- 41:13Speaker 1: or less of our particular people you think would be
- 41:15Speaker 1: good on the show. You can also find me on
- 41:17Speaker 1: x and on LinkedIn. Our show is produced by Gabriel
- 41:20Speaker 1: Hunter Chang and Trina Menino. Our editor is Lydia Jean
- 41:24Speaker 1: Kott and our engineer is Sarah Bruguier. I'm Jacob Goldstein
- 41:27Speaker 1: and we'll be back next week with another episode of
- 41:29Speaker 1: What's Your b